Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP715460.RAey2VCa91cuiwElQbRGnMD8wc42d1YwjMbHzv4UnukwU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP715460.RAey2VCa91cuiwElQbRGnMD8wc42d1YwjMbHzv4UnukwU130_assertion type Assertion NP715460.RAey2VCa91cuiwElQbRGnMD8wc42d1YwjMbHzv4UnukwU130_head.
- NP715460.RAey2VCa91cuiwElQbRGnMD8wc42d1YwjMbHzv4UnukwU130_assertion description "[Somatic epidermal growth factor receptor (EGFR) mutations in exons 19 and 21 have been found in non-small cell lung cancer (NSCLC) and are associated with the therapeutic response to gefitinib in patients with advanced NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715460.RAey2VCa91cuiwElQbRGnMD8wc42d1YwjMbHzv4UnukwU130_provenance.
- NP715460.RAey2VCa91cuiwElQbRGnMD8wc42d1YwjMbHzv4UnukwU130_assertion evidence source_evidence_literature NP715460.RAey2VCa91cuiwElQbRGnMD8wc42d1YwjMbHzv4UnukwU130_provenance.
- NP715460.RAey2VCa91cuiwElQbRGnMD8wc42d1YwjMbHzv4UnukwU130_assertion SIO_000772 19155283 NP715460.RAey2VCa91cuiwElQbRGnMD8wc42d1YwjMbHzv4UnukwU130_provenance.
- NP715460.RAey2VCa91cuiwElQbRGnMD8wc42d1YwjMbHzv4UnukwU130_assertion wasDerivedFrom befree-2016 NP715460.RAey2VCa91cuiwElQbRGnMD8wc42d1YwjMbHzv4UnukwU130_provenance.
- NP715460.RAey2VCa91cuiwElQbRGnMD8wc42d1YwjMbHzv4UnukwU130_assertion wasGeneratedBy ECO_0000203 NP715460.RAey2VCa91cuiwElQbRGnMD8wc42d1YwjMbHzv4UnukwU130_provenance.